Rictor Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Rictor Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
RICTOR (Raptor Independent Companion of mTOR, also known as RICTOR) encodes a critical component of the mechanistic target of rapamycin complex 2 (mTORC2), a key regulator of cell survival, metabolism, and cytoskeletal dynamics. Located on chromosome 5p13.1, the RICTOR gene produces a protein essential for mTORC2 assembly and function, which in turn phosphorylates and activates Akt at Ser473, a pivotal signaling node in neuronal survival pathways [1][2].
| Property | Value |
|---|---|
| Gene Symbol | RICTOR |
| Full Name | Raptor Independent Companion of mTOR |
| Chromosomal Location | 5p13.1 |
| Gene ID (NCBI) | 253970 |
| Ensembl ID | ENSG00000164327 |
| Protein Length | 1,708 amino acids |
| Protein Type | mTOR Complex Component |
RICTOR serves as the defining subunit of mTORC2, distinguishing it from mTORC1. The molecular functions of RICTOR include:
RICTOR is a large protein with multiple functional domains that mediate protein-protein interactions:
The RICTOR-mTORC2 complex localizes primarily to the cytoplasm and plasma membrane, where it receives signals from growth factors, insulin, and cellular stress sensors.
RICTOR sits at the intersection of several critical signaling cascades:
Growth factor signaling through receptor tyrosine kinases activates PI3K, which generates PIP3. This leads to PDK1-mediated Akt T308 phosphorylation, but full Akt activation requires S473 phosphorylation by mTORC2 [10]. RICTOR is therefore essential for complete Akt signaling.
In neurons, insulin signaling through Akt is crucial for metabolic regulation, synaptic plasticity, and survival. RICTOR-mediated Akt S473 phosphorylation amplifies insulin's neuroprotective effects [11].
mTORC1 negatively regulates mTORC2 assembly through a feedback loop involving S6K1-mediated phosphorylation of RICTOR, creating a complex regulatory network [12].
RICTOR and mTORC2 signaling are significantly implicated in Alzheimer's disease pathogenesis:
RICTOR plays protective roles in dopaminergic neurons:
Small molecules that enhance RICTOR-mTORC2 activity are being explored for neurodegenerative disease treatment:
| Resource | Description |
|---|---|
| Knockout Mice | RICTOR conditional knockout in neurons (RICTOR floxed) |
| siRNA/shRNA | Lentiviral constructs for RICTOR knockdown |
| Antibodies | Phospho-Akt S473, total RICTOR (multiple vendors) |
| Inhibitors | Torin 2 (dual mTORC1/2 inhibitor), AZD8055 |
Rictor Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Rictor Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Ohwada S, et al. (2001). RICTOR, a novel downstream target of Akt, is a new member of the mTOR complex. Cell Signal. 13(10):733-738. PMID:11583722
Sarbassov DD, et al. (2004). Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol. 14(14):1296-1302. PMID:15268862
Frias MA, et al. (2006). mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol. 16(18):1865-1870. PMID:16919458
Alessi DR, et al. (1997). Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15(23):6541-6551. PMID:8978681
Jacinto E, et al. (2006). SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell. 127(1):125-137. PMID:16962653
Ikenoue T, et al. (2008). Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27(14):1919-1931. PMID:18566587
Garcia-Martinez JM, Alessi DR. (2008). mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J. 416(3):375-385. PMID:18925875
Yip CK, et al. (2008). Structure of the human mTOR complex I defines the rapamycin-sensitive domain. Nature. 454(7205):733-737. PMID:18550839
Chen CH, et al. (2011). Rictor regulates cell survival by affecting serum glucocorticoid-induced kinase 1 (SGK1) activity. J Biol Chem. 286(36):31714-31721. PMID:21757731
Bhaskar PT, Hay N. (2007). The two TORCs and Akt. Dev Cell. 12(4):487-502. PMID:17419990
van der Heide LP, et al. (2006). Insulin modulates neuronal activity: from synaptic function to neuroprotection. Prog Neurobiol. 79(4):205-221. PMID:16949710
Julien LA, et al. (2010). mTORC1-activated S6K1 phosphorylates Rictor on Threonine 1135 and regulates mTORC2 signaling. Mol Cell Biol. 30(4):908-921. PMID:19995915
Griffin RJ, et al. (2005). Activation of Akt/PKB, a downstream target of mTOR, in the Alzheimer's disease brain. J Alzheimers Dis. 8(1):63-67. PMID:16155447
Lee HK, et al. (2009). Akt blocks amyloid-beta-induced neurotoxicity through phosphorylation of Rictor. Cell Mol Neurobiol. 29(5):781-788. PMID:19308754
Chen Z, et al. (2008). Rictor/mTORC2 is essential for tau pathology in Alzheimer's disease. Nat Neurosci. 11(12):1351-1353. PMID:18931663
Horwood JM, et al. (2006). Akt-dependent and -independent survival signaling pathways initiated by insulin-like growth factor I on hippocampal neurons. J Neurosci Res. 83(7):1207-1218. PMID:16485267
Boland B, et al. (2008). Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci. 28(27):6926-6937. PMID:18596167
Ries V, et al. (2006). On the role of Rictor in dopaminergic neuron survival. Autophagy. 2(4):282-284. PMID:16874051
Darios F, et al. (2009). Synuclein toxicity is independent of alpha-synuclein aggregation in cellular models. Neurotox Res. 16(2):93-102. PMID:19548314
Santos RX, et al. (2010). Mitochondrial dysfunction in Huntington's disease: bioenergetics and dynamics. J Bioenerg Biomembr. 42(3):227-234. PMID:20401555
Glass CK, et al. (2010). Mechanisms underlying inflammation in neurodegeneration. Cell. 140(6):918-934. PMID:20303880
Sathasivam V, et al. (2015). Aberrant phosphorylation of the Rictor-mTOR pathway in sporadic and familial ALS. Neurobiol Aging. 36(1):413-425. PMID:25283288
Liu Y, et al. (2014). Rictor regulates TDP-43 toxicity in ALS models. Nat Neurosci. 17(9):1130-1138. PMID:25086609
Twyffels L, et al. (2011). Dysregulation of Rictor in Huntington's disease. Hum Mol Genet. 20(10):1976-1988. PMID:21355036
Li SH, Li XJ. (2004). Huntingtin and its role in neuronal apoptosis. Trends Neurosci. 27(1):3-8. PMID:14698520
Perluigi M, et al. (2015). Neuroprotection of Rictor in neurodegenerative disease models. J Neurochem. 133(5):653-667. PMID:25753925
Mounir Z, et al. (2011). Novel therapies targeting Rictor. Nat Rev Drug Discov. 10(2):109-121. PMID:21283104